Selected research
Market Analysis & Forecast
Global Sotalol Market Analysis and Forecast 2026-2032
Market perspective
The global Sotalol market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Sotalol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Sotalol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Sotalol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Sotalol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Sotalol include Shaanxi Hanjiang Pharmaceutical Group, GSK, Bayer, Samarth Pharma Pvt. Ltd., Cipla Limited, Cambrex, Bristol-Myers Squibb (BMS), Arevipharma and Arbor Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Sotalol, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Sotalol, also provides the sales of main regions and countries. Of the upcoming market potential for Sotalol, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sotalol sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Sotalol market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Sotalol sales, projected growth trends, production technology, application and end-user industry.
Sotalol Segment by Company
Shaanxi Hanjiang Pharmaceutical Group
GSK
Bayer
Samarth Pharma Pvt. Ltd.
Cipla Limited
Cambrex
Bristol-Myers Squibb (BMS)
Arevipharma
Arbor Pharmaceuticals
Sotalol Segment by Type
40mg Sotalol
80mg Sotalol
Sotalol Segment by Application
Sustained Ventricular Tachycardia
Atrial Fibrillation/Flutter
Sotalol Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sotalol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sotalol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sotalol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Sotalol in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Sotalol manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sotalol sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 40mg Sotalol
- 80mg Sotalol
Applications
- Sustained Ventricular Tachycardia
- Atrial Fibrillation/Flutter
Companies covered
- Shaanxi Hanjiang Pharmaceutical Group
- GSK
- Bayer
- Samarth Pharma Pvt. Ltd.
- Cipla Limited
- Cambrex
- Bristol-Myers Squibb (BMS)
- Arevipharma
- Arbor Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Sotalol Market by Type
- 1.2.1 Global Sotalol Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 40mg Sotalol
- 1.2.3 80mg Sotalol
- 1.3 Sotalol Market by Application
- 1.3.1 Global Sotalol Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Sustained Ventricular Tachycardia
- 1.3.3 Atrial Fibrillation/Flutter
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Sotalol Market Dynamics
- 2.1 Sotalol Industry Trends
- 2.2 Sotalol Industry Drivers
- 2.3 Sotalol Industry Opportunities and Challenges
- 2.4 Sotalol Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Sotalol Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Sotalol Revenue by Region
- 3.2.1 Global Sotalol Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Sotalol Revenue by Region (2021-2026)
- 3.2.3 Global Sotalol Revenue by Region (2027-2032)
- 3.2.4 Global Sotalol Revenue Market Share by Region (2021-2032)
- 3.3 Global Sotalol Sales Estimates and Forecasts 2021-2032
- 3.4 Global Sotalol Sales by Region
- 3.4.1 Global Sotalol Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Sotalol Sales by Region (2021-2026)
- 3.4.3 Global Sotalol Sales by Region (2027-2032)
- 3.4.4 Global Sotalol Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Sotalol Revenue by Manufacturers
- 4.1.1 Global Sotalol Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Sotalol Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Sotalol Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Sotalol Sales by Manufacturers
- 4.2.1 Global Sotalol Sales by Manufacturers (2021-2026)
- 4.2.2 Global Sotalol Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Sotalol Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Sotalol Sales Price by Manufacturers (2021-2026)
- 4.4 Global Sotalol Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Sotalol Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Sotalol Manufacturers, Product Type & Application
- 4.7 Global Sotalol Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Sotalol Market CR5 and HHI
- 4.8.2 2025 Sotalol Tier 1, Tier 2, and Tier 3
5 Sotalol Market by Type
- 5.1 Global Sotalol Revenue by Type
- 5.1.1 Global Sotalol Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Sotalol Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Sotalol Revenue Market Share by Type (2021-2032)
- 5.2 Global Sotalol Sales by Type
- 5.2.1 Global Sotalol Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Sotalol Sales by Type (2021-2032) & (m units)
- 5.2.3 Global Sotalol Sales Market Share by Type (2021-2032)
- 5.3 Global Sotalol Price by Type
6 Sotalol Market by Application
- 6.1 Global Sotalol Revenue by Application
- 6.1.1 Global Sotalol Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Sotalol Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Sotalol Revenue Market Share by Application (2021-2032)
- 6.2 Global Sotalol Sales by Application
- 6.2.1 Global Sotalol Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Sotalol Sales by Application (2021-2032) & (m units)
- 6.2.3 Global Sotalol Sales Market Share by Application (2021-2032)
- 6.3 Global Sotalol Price by Application
7 Company Profiles
- 7.1 Shaanxi Hanjiang Pharmaceutical Group
- 7.1.1 Shaanxi Hanjiang Pharmaceutical Group Company Information
- 7.1.2 Shaanxi Hanjiang Pharmaceutical Group Business Overview
- 7.1.3 Shaanxi Hanjiang Pharmaceutical Group Sotalol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Shaanxi Hanjiang Pharmaceutical Group Sotalol Product Portfolio
- 7.1.5 Shaanxi Hanjiang Pharmaceutical Group Recent Developments
- 7.2 GSK
- 7.2.1 GSK Company Information
- 7.2.2 GSK Business Overview
- 7.2.3 GSK Sotalol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 GSK Sotalol Product Portfolio
- 7.2.5 GSK Recent Developments
- 7.3 Bayer
- 7.3.1 Bayer Company Information
- 7.3.2 Bayer Business Overview
- 7.3.3 Bayer Sotalol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Bayer Sotalol Product Portfolio
- 7.3.5 Bayer Recent Developments
- 7.4 Samarth Pharma Pvt. Ltd.
- 7.4.1 Samarth Pharma Pvt. Ltd. Company Information
- 7.4.2 Samarth Pharma Pvt. Ltd. Business Overview
- 7.4.3 Samarth Pharma Pvt. Ltd. Sotalol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Samarth Pharma Pvt. Ltd. Sotalol Product Portfolio
- 7.4.5 Samarth Pharma Pvt. Ltd. Recent Developments
- 7.5 Cipla Limited
- 7.5.1 Cipla Limited Company Information
- 7.5.2 Cipla Limited Business Overview
- 7.5.3 Cipla Limited Sotalol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Cipla Limited Sotalol Product Portfolio
- 7.5.5 Cipla Limited Recent Developments
- 7.6 Cambrex
- 7.6.1 Cambrex Company Information
- 7.6.2 Cambrex Business Overview
- 7.6.3 Cambrex Sotalol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Cambrex Sotalol Product Portfolio
- 7.6.5 Cambrex Recent Developments
- 7.7 Bristol-Myers Squibb (BMS)
- 7.7.1 Bristol-Myers Squibb (BMS) Company Information
- 7.7.2 Bristol-Myers Squibb (BMS) Business Overview
- 7.7.3 Bristol-Myers Squibb (BMS) Sotalol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Bristol-Myers Squibb (BMS) Sotalol Product Portfolio
- 7.7.5 Bristol-Myers Squibb (BMS) Recent Developments
- 7.8 Arevipharma
- 7.8.1 Arevipharma Company Information
- 7.8.2 Arevipharma Business Overview
- 7.8.3 Arevipharma Sotalol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Arevipharma Sotalol Product Portfolio
- 7.8.5 Arevipharma Recent Developments
- 7.9 Arbor Pharmaceuticals
- 7.9.1 Arbor Pharmaceuticals Company Information
- 7.9.2 Arbor Pharmaceuticals Business Overview
- 7.9.3 Arbor Pharmaceuticals Sotalol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Arbor Pharmaceuticals Sotalol Product Portfolio
- 7.9.5 Arbor Pharmaceuticals Recent Developments
8 North America
- 8.1 North America Sotalol Market Size by Type
- 8.1.1 North America Sotalol Revenue by Type (2021-2032)
- 8.1.2 North America Sotalol Sales by Type (2021-2032)
- 8.1.3 North America Sotalol Price by Type (2021-2032)
- 8.2 North America Sotalol Market Size by Application
- 8.2.1 North America Sotalol Revenue by Application (2021-2032)
- 8.2.2 North America Sotalol Sales by Application (2021-2032)
- 8.2.3 North America Sotalol Price by Application (2021-2032)
- 8.3 North America Sotalol Market Size by Country
- 8.3.1 North America Sotalol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Sotalol Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Sotalol Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Sotalol Market Size by Type
- 9.1.1 Europe Sotalol Revenue by Type (2021-2032)
- 9.1.2 Europe Sotalol Sales by Type (2021-2032)
- 9.1.3 Europe Sotalol Price by Type (2021-2032)
- 9.2 Europe Sotalol Market Size by Application
- 9.2.1 Europe Sotalol Revenue by Application (2021-2032)
- 9.2.2 Europe Sotalol Sales by Application (2021-2032)
- 9.2.3 Europe Sotalol Price by Application (2021-2032)
- 9.3 Europe Sotalol Market Size by Country
- 9.3.1 Europe Sotalol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Sotalol Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Sotalol Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Sotalol Market Size by Type
- 10.1.1 China Sotalol Revenue by Type (2021-2032)
- 10.1.2 China Sotalol Sales by Type (2021-2032)
- 10.1.3 China Sotalol Price by Type (2021-2032)
- 10.2 China Sotalol Market Size by Application
- 10.2.1 China Sotalol Revenue by Application (2021-2032)
- 10.2.2 China Sotalol Sales by Application (2021-2032)
- 10.2.3 China Sotalol Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Sotalol Market Size by Type
- 11.1.1 Asia Sotalol Revenue by Type (2021-2032)
- 11.1.2 Asia Sotalol Sales by Type (2021-2032)
- 11.1.3 Asia Sotalol Price by Type (2021-2032)
- 11.2 Asia Sotalol Market Size by Application
- 11.2.1 Asia Sotalol Revenue by Application (2021-2032)
- 11.2.2 Asia Sotalol Sales by Application (2021-2032)
- 11.2.3 Asia Sotalol Price by Application (2021-2032)
- 11.3 Asia Sotalol Market Size by Country
- 11.3.1 Asia Sotalol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Sotalol Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Sotalol Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Sotalol Market Size by Type
- 12.1.1 SAMEA Sotalol Revenue by Type (2021-2032)
- 12.1.2 SAMEA Sotalol Sales by Type (2021-2032)
- 12.1.3 SAMEA Sotalol Price by Type (2021-2032)
- 12.2 SAMEA Sotalol Market Size by Application
- 12.2.1 SAMEA Sotalol Revenue by Application (2021-2032)
- 12.2.2 SAMEA Sotalol Sales by Application (2021-2032)
- 12.2.3 SAMEA Sotalol Price by Application (2021-2032)
- 12.3 SAMEA Sotalol Market Size by Country
- 12.3.1 SAMEA Sotalol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Sotalol Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Sotalol Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Sotalol Value Chain Analysis
- 13.1.1 Sotalol Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Sotalol Production Mode & Process
- 13.2 Sotalol Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Sotalol Distributors
- 13.2.3 Sotalol Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst